Acoustic Imaging's John Kingsley dies

Article

John T. Kingsley, chief executive officer of Acoustic ImagingTechnologies, died August 24 at a Phoenix hospice after a five-monthbout with cancer. He was 53. Kingsley was widely respected for his creative approach toultrasound product development and

John T. Kingsley, chief executive officer of Acoustic ImagingTechnologies, died August 24 at a Phoenix hospice after a five-monthbout with cancer. He was 53.

Kingsley was widely respected for his creative approach toultrasound product development and persistence in reinforcingAI's market position in a highly competitive industry segment.

"He introduced three major new products, put in placea sound management structure and established an operating philosophybased on a vision of sustained growth in core businesses and technologicalleadership," said Steven Kaska, worldwide director of strategicmarketing.

Kingsley joined AI in 1992 as vice president of engineeringand product development and was promoted to president and chiefexecutive officer in January 1993.

Richard Monaco, vice-president of operations, will manage thefirm on an interim basis, Kaska said.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.